Provectus Biopharmaceuticals, Inc.../ US74373P1084 /
| 2024-05-03 9:59:53 PM | Chg. +0.0018 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.1931USD | +0.91% | 128,865 Turnover: 22,913.5795 |
-Bid Size: - | -Ask Size: - | 0.1980 | 0.1901 |
GlobeNewswire
05-02
Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of...
GlobeNewswire
04-18
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Pro...
GlobeNewswire
04-16
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder...
GlobeNewswire
04-11
Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC a...
GlobeNewswire
03-27
Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miam...
GlobeNewswire
03-12
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Benga...
GlobeNewswire
03-07
Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC a...
GlobeNewswire
02-29
Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstrac...
GlobeNewswire
2023-12-18
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodiu...
GlobeNewswire
2023-11-15
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutane...
GlobeNewswire
2023-11-13
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uvea...
GlobeNewswire
2023-11-06
Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at So...
GlobeNewswire
2022-03-24
Provectus Biopharmaceuticals Announces Synthesis of New Halogenated Xanthene Small Molecule
GlobeNewswire
2022-02-16
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Metastatic Uveal Melanoma Abstract for O...
GlobeNewswire
2022-02-08
Provectus Biopharmaceuticals Announces Acceptance of PV-10® Systemic Administration Abstract at Amer...
GlobeNewswire
2022-01-27
Provectus Biopharmaceuticals Provides Update on Research into PV-10® Immunotherapy as an Immune Adju...
GlobeNewswire
2022-01-10
Provectus Biopharmaceuticals Announces Publication of Pharmaceutical-Grade Rose Bengal’s Activity Ag...
GlobeNewswire
2021-11-01
Provectus Biopharmaceuticals Announces Presentation of Meta-Analysis Results of Single-Agent PV-10® ...
GlobeNewswire
2021-10-28
Provectus Biopharmaceuticals Announces Presentation of Updated Data from Combination Therapy Trial o...
GlobeNewswire
2021-10-04
Provectus Biopharmaceuticals Provides Update on Research into Oral Administration of PV-10® Immunoth...
GlobeNewswire
2021-09-27
Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melan...
